SeedToB Capital

Type

Venture Capital

Status

Active

Location

Atlanta, United States

Total investments

19

Average round size

1M

Portfolio companies

15

Rounds per year

4.75

Lead investments

4

Follow on index

0.21

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyAnalyticsArtificial IntelligenceHealth CareHealth DiagnosticsWellnessMedical DeviceMedicalPersonal HealthPsychology

Investor highlights

Industry focus
Healthcare
Stage focus
Series ASeries BSeed
Geo focus
United States
Check size
500K — 2M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 30000000
Fund raised date
2021-03-12

Analytics

Total investments
19
Lead investments
4
Rounds per year
4.75
Follow on index
0.21
Investments by industry
  • Health Care (15)
  • Biotechnology (7)
  • Health Diagnostics (6)
  • Wellness (6)
  • Medical (4)
  • Show 28 more
Investments by region
  • United States (17)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Group Appearance index
0.68

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Candid 21 Sep 2023 Health Care, Wellness, Data Center Automation Seed 1M
Epinoma 21 Oct 2021 Biotechnology, Health Diagnostics, Life Science Seed United States, California, San Francisco
Utrip RPA 08 Jun 2022 SaaS, Apps, Travel, Travel Agency Seed Seoul, Seoul-t'ukpyolsi, South Korea
Vizibility 22 Sep 2011 Mobile, Search Engine, Brand Marketing, SEO, Reputation Early Stage Venture 2M United States, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.